Study finds limited effectiveness of non-surgical treatments for back pain
Only around 1 in 10 common non-surgical and non-invasive treatments for lower back pain is effective, suggests a pooled data ...
Tag: Placebo
How your gut microbiome shapes anxiety
A recent study explores the intricate connection between gut bacteria and mental health, revealing how microbiome imbalances may contribute to ...
Insilico Medicine's AI-driven drug Rentosertib receives official generic name
Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic ...
The Future of CBD research, marketing, and regulation
In this interview, Professor Ted Dinan, Medical Director at Atlantia Clinical Trials, and Asa Waldstein, Principal at Supplement Advisory Group, ...
The brain-gut microbiota axis: Impact on mental health & potential treatment avenues
Gut-microbiota has been found in recent years to have a significant impact on both physical and mental health. Ted Dinan, ...
Vitamin E significantly improves liver health in MASH patients, new study finds
New research shows that Vitamin E therapy significantly enhances liver function and reduces inflammation in MASH patients, providing a safer ...
Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Low-dose semaglutide reduces alcohol consumption and cravings in early trial
Study finds significant reductions in drinks per drinking day and alcohol craving, with potential benefits for smoking reduction Study: Once-Weekly ...
AstraZeneca receives positive NICE recommendations for lung cancer treatment
AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence ...
Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity
A multicentre trial in China finds that combining SGLT-2 inhibitors with calorie restriction improves remission, weight loss, and metabolic health ...